Osterweis Capital Management Inc Revance Therapeutics, Inc. Transaction History

Osterweis Capital Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$24.03 - $29.97 $4.2 Million - $5.24 Million	-174,970 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$23.41 - $28.34 $483,065 - $584,795	-20,635 Reduced 10.55%	174,970 $4.96 Million
Q3 2020 Nov 13, 2020	SELL	$23.23 - $34.3 $775,998 - $1.15 Million	-33,405 Reduced 14.59%	195,605 $4.92 Million
Q2 2020 Aug 14, 2020	SELL	$12.6 - $26.55 $32,760 - $69,030	-2,600 Reduced 1.12%	229,010 $5.59 Million
Q1 2020 May 15, 2020	BUY	$12.46 - $27.81 $272,001 - $607,092	21,830 Added 10.41%	231,610 $3.43 Million
Q4 2019 Feb 14, 2020	BUY	$11.66 - $20.15 $2.45 Million - $4.23 Million	209,780 New	209,780 $3.41 Million

234

82.8M

680K

896K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of Osterweis Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Osterweis Capital Management Inc with notifications on news.